Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation

Basic Research in Cardiology

Volumn 105, Issue 2, 2010, Pages 267-277

  Willert, Manuela ^a   Augstein, Antje ^a   Poitz, David M ^a   Schmeisser, Alexander ^b   Strasser, Ruth H ^a   Braun Dullaeus, Ruediger Christian ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Platelet derived growth factor; Signal transduction; Smooth muscle

Indexed keywords

ANGIOTENSIN II; BROXURIDINE; HYDROGEN PEROXIDE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C; PROTEIN KINASE PIM 1; SHORT HAIRPIN RNA; VASCULOTROPIN 165; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PIM1 PROTEIN, MOUSE; PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HALF LIFE TIME; HYPOXIA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; C57BL MOUSE; CELL CULTURE; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; JANUS KINASES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-PIM-1;

EID: 77950343957     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-009-0055-x     Document Type: Article

References (51)

1. Aho TL, Lund RJ, Ylikoski EK, Matikainen S, Lahesmaa R, Koskinen PJ (2005) Expression of human Pim family genes is selectively up-regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation. Immunology 116:82-88 (Pubitemid 41208355)
2. Amaravadi R, Thompson CB (2005) The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115:2618-2624 (Pubitemid 41434384)
3. Bachmann M, Hennemann H, Xing PX, Hoffmann I, Moroy T (2004) The Oncogenic Serine/Threonine Kinase Pim-1 Phosphorylates and Inhibits the Activity of Cdc25C-associated Kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem 279:48319-48328 (Pubitemid 39540988)
4. BanaiS,WolfY,GolombG,PearleA,WaltenbergerJ,FishbeinI,SchneiderA,GazitA, PerezL,HuberR,LazarovichiG,RabinovichL,LevitzkiA,GertzSD(1998) PDGF-receptortyrosinekinaseblockerAG1295selectivelyattenuatessmoothmusclece llgrowthinvitroandreducesneointimalformationafterballoonangioplastyinswine. Circulation97:1960-1969(Pubitemid28222191)
5. BerraE,az-MecoMT,DomínguezI,MunicioMM,SanzL,LozanoJ,ChapkinRS, MoscatJ(1993)ProteinkinaseC[zeta] isoformiscriticalformitogenicsignaltransduction.Cell74:555- 563(Pubitemid23244620)
6. Buckley AR (2000) Transcriptional regulation of Pim-1 by prolactin: independence of a requirement for Jak2/Stat signaling. J Neuroimmunol 109:40-46
7. Chittenden TW, Sherman JA, Xiong F, Hall AE, Lanahan AA, Taylor JM, Duan H, Pearlman JD, Moore JH, Schwartz SM, Simons M (2006) Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 114:1811-1820
8. CuypersHT,SeltenG,QuintW,ZijlstraM,MaandagER,BoelensW,vanWezenbeekP, MeliefC,BernsA(1984)Murineleukemiavirus-inducedT-celllymphomagenesis: integrationofprovirusesinadistinctchromosomalregion.Cell37:141- 150(Pubitemid14079845)
9. DixonBS,SharmaRV,DickersonT,FortuneJ(1994)BradykininandangiotensinII: activationofproteinkinaseCinarterialsmoothmuscle.AmJPhysiolCellPhysiol266: C1406-C1420(Pubitemid24170670)
10. Dwivedi A, Sala-Newby GB, George SJ (2008) Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening. Basic Res Cardiol 103:244-256
11. Dzau VJ, Braun-Dullaeus RC, Sedding DG (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8:1249-1256
12. Erbel C, Sato K, Meyer EB, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM (2007) Functional profile of activated dendritic cells in unstable atherosclerotic plaque. Basic Res Cardiol 102:123-132 (Pubitemid 46189953)
13. Fox CJ, Hammerman PS, Thompson CB (2005) The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 201:259-266
14. Frank GD, Inagami T (2006) PDGF induces a ROS and Src kinase-dependent PKC-delta Tyr-311 phosphorylation promoting vascular smooth muscle cell growth and proliferation. FASEB J 20:LB16-LB1a
15. Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB (2005) Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105:4477-4483
16. Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, Lilly MB (2007) Characterization of a potent and selective small-molecule inhibitor of the Pim 1 kinase. Mol Cancer Ther 6:163-172 (Pubitemid 46206679)
17. HooverDS,WingettDG,ZhangJ,ReevesR,MagnusonNS(1997)Pim- 1proteinexpressionisregulatedbyits5′'- untranslatedregionandtranslationinitiationfactorelF-4E.CellGrowthDiffer8: 1371-1380(Pubitemid28008733)
18. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98:2108-2116
19. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NCP (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106:2162-2168 (Pubitemid 41291734)
20. Kalsch T, Elmas E, Nguyen XD, Suvajac N, Kluter H, Borggrefe M, Dempfle CE (2007) Endotoxin-induced effects on platelets and monocytes in an in vivo model, of inflammation, Basic Res Cardiol 102:460-466 (Pubitemid 47278819)
21. Katakami N, Kanete H, Hao H, Umayahara Y, Fujitani Y, Sakamoto K, Si Gorogawa, Yasuda T, Kawamori D, Kajimoto Y, Matsuhisa M, Yutani C, Hori M, Yamasaki Y (2004) Role of Pim-1 in smooth muscle cell proliferation. J Biol Chem 279:54742-54749 (Pubitemid 40053219)
22. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779-1790 (Pubitemid 40570926)
23. Krishnan N, Pan H, Buckley DJ, Buckley A (2003) Prolactinregulated Pim-1 transcription: identification of critical promoter elements and Akt signaling. Endocrine 20:123-130
24. Langer HF, Gawaz M. (2008) Platelets in regenerative medicine. Basic Res Cardiol 103:299-307
25. Losman JA, Chen XP, Vuong BQ, Fay S, Rothman PB (2003) Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem 278:4800-4805 (Pubitemid 36800983)
26. Martiny-BaronG,KazanietzMG,MischakH,BlumbergPM,KochsG,HugH,ManneD, SchachteleC(1993) SelectiveinhibitionofproteinkinaseCisozymesbytheindolocarbazoleGo6976. JBiolChem268:9194-9197(Pubitemid23145960)
27. Mikkers H, Nawijn M, Allen J, Brouwers C, Verhoeven E, Jonkers J, Berns A (2004) Mice deficient for all Pim kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 24:6104-6115 (Pubitemid 38787993)
28. MiuraO,MiuraY,NakamuraN,QuelleFW,WitthuhnBA,IhleJN,AokiN(1994) InductionoftyrosinephosphorylationofVavandexpressionofPim-1correlateswithJak2- mediatedgrowthsignalingfromtheerythropoietinreceptor.Blood84: 4135-4141(Pubitemid24371915)
29. Mizuno K, Shirogane T, Shinohara A, Iwamatsu A, Hibi M, Hirano T (2001) Regulation of Pim-1 by Hsp90. Biochem Biophys Res Commun 281:663-669
30. Nagarajan L, Narayana L (1993) Transcriptional attenuation of Pim-1 gene. Biochem Biophys Res Commun 190:435-439
31. Okazaki J, Mawatari K, Liu B, Kent KC (2000) The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production. Surgery 128:192-197 (Pubitemid 30622483)
32. Padma R, Nagarajan L (1991) The human Pim-1 gene product is a protein serine kinase. Cancer Res 51:2486-2489
33. Palaty CK, Kalmar G, Tai G, Oh S, Amankawa L, Affolter M, Aebersold R, Pelech SL (1997) Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 Proto-oncogeneencoded protein kinase. J Biol Chem 272:10514-10521
34. Panek RL, Dahring TK, Olszewski BJ, Keiser JA (1997) PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery. Arterioscler Thromb Vase Biol 17:1283-1288
35. Parmentier JH, Smelcer P, Pavicevic Z, Basic E, Idrizovic A, Estes A, Malik KU (2003) PKC-(zeta) mediates norepinephrineinduced phospholipase D activation and cell proliferation in VSMC. Hypertension 41:794-800 (Pubitemid 36314593)
36. PatelNA,ChalfantCE,YamamotoM,WatsonJE,EichlerDC,CooperDR(1999) AcutehyperglycemiaregulatestranscriptionandposttranscriptionalstabilityofPKC- IImRNAinvascularsmoothmusclecells.FASEBJ13:103-113(Pubitemid29038280)
37. Qian KC, Wang L, Hickey ER, Studts J, Barringer K, Peng C, Kronkaitis A, Li J, White A, Mische S, Farmer B (2005) Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase. J Biol Chem 280:6130-6137
38. Robin P, Boulven I, Bole-Feysot C, Tanfin Z, Leiber D (2004) Contribution of PKC-dependent and -independent processes in temporal ERK regulation by ET-1, PDGF, and EGF in rat myometrial cells. Cell Physiol 286:C798-C806
39. Ross R (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57:791-804
40. Ross R (1999) Atherosclerosis- an inflammatory disease. N Engl J Med 340:115-126
41. Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell. Science 180:1332-1339
42. Selten G, Cuypers HT, Berns A (1985) Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J 4:1793-1798
43. ShiroganeT,FukadaT,MullerJM,ShimaDT,HibiM,HiranoT(1999) SynergisticrolesforPim-1andc-MycinSTAT3- mediatedcellcycleprogressionandantiapoptosis.Immunity11:709- 719(Pubitemid30030710)
44. Stout BA, Bates ME, Liu LY, Farrington NN, Bertics PJ (2004) IL5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J Immunol 173:6409-6417
45. Wang Z, Bhattacharya N, Mixter PF, Wei W, Sedivy J, Magnuson NS (2002) Phosphorylation of the cell cycle inhibitor p21Cip1/WAFl by Pim-1 kinase. Biochim Biophys Acta Mol Cell Res 1593:45-55 (Pubitemid 35335911)
46. Wingett D, Reeves R, Magnuson NS (1991) Stability changes in Pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J Immunol 147:3653-3659
47. Yamamoto M, cevedo-Duncan M, Chalfant CE, Patel NA, Watson JE, Cooper DR (1998) The roles of protein kinase C beta I and beta II in vascular smooth muscle cell proliferation. Exp Cell Res 240:349-358 (Pubitemid 28371116)
48. Yip-Schneider MT, Horie M, Broxmeyer HE (1995) Transcriptional induction of Pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor. Blood 85:3494-3502
49. Zhang Y, Wang Z, Magnuson NS (2007) Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 Cells. Mol Cancer Res 5:909-922 (Pubitemid 47416668)
50. Zhao Y, Liu J, Li L, Liu L, Wu L (2005) Role of Ras/PKC[zeta]/ MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul Pept 128:43-50
51. Zippo A, De Robertis A, Bardelli M, Galvagni F, Oliviero S (2004) Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103:4536-4544 (Pubitemid 38745981)